STARNIPHA FLETCHER: Open Payments
NPI 1639205446 · MT VERNON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 55 payments from 11 companies in 2025. Trend: 2023 $1,613 · 2024 $1,228 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $747 |
| Axsome Therapeutics, Inc. | 6 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $115 |
| Alkermes, Inc. | 3 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Tris Pharma Inc | 3 | $65 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: VRAYLAR, Auvelity, CAPLYTA, REXULTI, LYBALVI, Dyanavel XR, Qelbree, INGREZZA.
Industry payments across NY — which companies pay providers there.
